Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04302428 · ClinicalTrials.gov registry record
Zinc Status and Growth in Cystic Fibrosis
A clinical trial, sponsored by Indiana University.
- Completed
- Registry status
- 35
- Enrollment target
NCT04302428: Completed study, sponsored by Indiana University.
NCT04302428 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 35 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04302428 has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 35 participants
- Enrollment target
Study Summary
The purpose of this study is to improve the understanding of the relationship of zinc status and growth in infants and young children who were diagnosed with cystic fibrosis via newborn screening.
Primary Outcome
Zn status in infant and young PWCF as measured by serum Zn and red blood cell Zn
Interventions
- BIOLOGICAL Serum Zn
- BIOLOGICAL Red Blood Cell Zn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2019-08-29 |
| Est. Completion | 2021-03-30 |
What the finished NCT04302428 record still lists
NCT04302428 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 35 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Serum Zn is the first listed.
NCT04302428 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04302428 about?
NCT04302428 is a clinical study titled "Zinc Status and Growth in Cystic Fibrosis". The purpose of this study is to improve the understanding of the relationship of zinc status and growth in infants and young children who were diagnosed with cystic fibrosis via newborn screening.
What is the current status of trial NCT04302428?
This trial is currently completed. The enrollment target is 35 participants. The study started on 2019-08-29. Estimated completion is 2021-03-30.
What interventions are being tested in trial NCT04302428?
The interventions under investigation include: Serum Zn (BIOLOGICAL), Red Blood Cell Zn (BIOLOGICAL).
Who is sponsoring clinical trial NCT04302428?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI